Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Largactil 2ml solution recalled

The Medicines and Health products Regulatory Agency has reported that two batches of Largactil 50mg/2ml solution for injection from Aventis Pharma Ltd (Sanofi) have now been recalled.

Sanofi has pulled back the product due to impurity which was suspected to have been caused by increased oxidation as a result of higher oxygen content in the headspace of the ampoules, the MHRA has said.


ProductBatch NumberExpiry DatePack SizeFirst Distributed
Largactil 50mg/2ml solution for injectionA9014205/202210 x 2ml ampoules8th April 2020
A9014305/202210 x 2ml ampoules10th June 2020

Healthcare professionals have been advised to stop supplying the batches immediately and quarantine all stock and return the same to their supplier.